Logo
ScienceStack
Table of Contents
Fetching ...
Sign In

Optimizing Medication Decisions for Patients with Atrial Fibrillation through Path Development Network

Tian Xie

TL;DR

The paper tackles how to better decide anticoagulant therapy for atrial fibrillation by predicting stroke risk from 12-lead ECG data. It introduces a path development layer that leverages Lie group–based time-series processing, integrated with CNNs and LSTMs, to extract robust features from ECG signals. Empirical results show that using the path development layer, especially when combined with LSTM, yields the highest specificity under a strict negative predictive value constraint, outperforming traditional LSTM alone and improving upon existing methods. This approach offers a pathway toward more personalized anticoagulation decisions, potentially reducing unnecessary anticoagulant use and its associated risks and costs, while highlighting directions for larger datasets and interpretability in clinical deployment.

Abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by rapid and irregular contractions of the atria. It significantly elevates the risk of strokes due to slowed blood flow in the atria, especially in the left atrial appendage, which is prone to blood clot formation. Such clots can migrate into cerebral arteries, leading to ischemic stroke. To assess whether AF patients should be prescribed anticoagulants, doctors often use the CHA2DS2-VASc scoring system. However, anticoagulant use must be approached with caution as it can impact clotting functions. This study introduces a machine learning algorithm that predicts whether patients with AF should be recommended anticoagulant therapy using 12-lead ECG data. In this model, we use STOME to enhance time-series data and then process it through a Convolutional Neural Network (CNN). By incorporating a path development layer, the model achieves a specificity of 30.6% under the condition of an NPV of 1. In contrast, LSTM algorithms without path development yield a specificity of only 2.7% under the same NPV condition.

Optimizing Medication Decisions for Patients with Atrial Fibrillation through Path Development Network

TL;DR

The paper tackles how to better decide anticoagulant therapy for atrial fibrillation by predicting stroke risk from 12-lead ECG data. It introduces a path development layer that leverages Lie group–based time-series processing, integrated with CNNs and LSTMs, to extract robust features from ECG signals. Empirical results show that using the path development layer, especially when combined with LSTM, yields the highest specificity under a strict negative predictive value constraint, outperforming traditional LSTM alone and improving upon existing methods. This approach offers a pathway toward more personalized anticoagulation decisions, potentially reducing unnecessary anticoagulant use and its associated risks and costs, while highlighting directions for larger datasets and interpretability in clinical deployment.

Abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by rapid and irregular contractions of the atria. It significantly elevates the risk of strokes due to slowed blood flow in the atria, especially in the left atrial appendage, which is prone to blood clot formation. Such clots can migrate into cerebral arteries, leading to ischemic stroke. To assess whether AF patients should be prescribed anticoagulants, doctors often use the CHA2DS2-VASc scoring system. However, anticoagulant use must be approached with caution as it can impact clotting functions. This study introduces a machine learning algorithm that predicts whether patients with AF should be recommended anticoagulant therapy using 12-lead ECG data. In this model, we use STOME to enhance time-series data and then process it through a Convolutional Neural Network (CNN). By incorporating a path development layer, the model achieves a specificity of 30.6% under the condition of an NPV of 1. In contrast, LSTM algorithms without path development yield a specificity of only 2.7% under the same NPV condition.
Paper Structure (34 sections, 9 theorems, 53 equations, 14 figures, 1 table, 2 algorithms)

This paper contains 34 sections, 9 theorems, 53 equations, 14 figures, 1 table, 2 algorithms.

Table of Contents

  1. Introduction
  2. Prerequisites on Machine Learning
  3. Neural networks
  4. Deep Neural Network, Convolutional Neural Networks
  5. Recurrent Neural Network, Long Short-Term Memory network
  6. Path Develepment
  7. Lie Group
  8. Optimization of Matrix Lie Groups
  9. Path Development Layer
  10. Backpropagation Algorithm in the Path Development Layer
  11. ECG Data Analysis
  12. Models for ECG
  13. ECG Dataset
  14. Data Preprocessing and Wavelet Transformation
  15. Data Augmentation
  16. ...and 19 more sections

Key Result

Theorem 1

cybenko1989approximation For a standard sigmoid activation function $\sigma$ (or other squashing functions), for any continuous function $f: [0, 1]^m \to \mathbb{R}$ and any $\epsilon > 0$, there exists a neural network $N_w$ such that: where

Figures (14)

  • Figure 1: positive ECG
  • Figure 2: negative ECG
  • Figure 3: Before wavelet transformation processing
  • Figure 4: After wavelet transformation processing
  • Figure 5: Network architecture diagram
  • ...and 9 more figures

Theorems & Definitions (10)

  • Theorem 1: Cybenko, 1989
  • Theorem 2: Hornik, 1991
  • Theorem 3: Pinkus, 1999
  • Theorem 4
  • Theorem 5
  • Theorem 6
  • Theorem 7
  • Theorem 8
  • proof
  • Theorem 9: No Free Lunch Theorem